Logo image of RBLX

ROBLOX CORP -CLASS A (RBLX) Stock Fundamental Analysis

NYSE:RBLX - New York Stock Exchange, Inc. - US7710491033 - Common Stock - Currency: USD

86.98  +2.19 (+2.58%)

After market: 86.95 -0.03 (-0.03%)

Fundamental Rating

3

Taking everything into account, RBLX scores 3 out of 10 in our fundamental rating. RBLX was compared to 72 industry peers in the Entertainment industry. RBLX scores quite bad on profitability, while its financial health is fine. Not spectacular, but in line with the averages. RBLX is valied quite expensively at the moment, while it does show a decent growth rate.


Dividend Valuation Growth Profitability Health

Quickly go to:

2

1. Profitability

1.1 Basic Checks

In the past year RBLX has reported negative net income.
RBLX had a positive operating cash flow in the past year.
RBLX had negative earnings in each of the past 5 years.
Each year in the past 5 years RBLX had a positive operating cash flow.
RBLX Yearly Net Income VS EBIT VS OCF VS FCFRBLX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2018 2019 2020 2021 2022 2023 2024 0 500M -500M -1B

1.2 Ratios

RBLX has a Return On Assets of -11.81%. This is in the lower half of the industry: RBLX underperforms 67.61% of its industry peers.
Looking at the Return On Equity, with a value of -283.19%, RBLX is doing worse than 80.28% of the companies in the same industry.
Industry RankSector Rank
ROA -11.81%
ROE -283.19%
ROIC N/A
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
RBLX Yearly ROA, ROE, ROICRBLX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2018 2019 2020 2021 2022 2023 2024 -500 -1K -1.5K

1.3 Margins

RBLX has a better Gross Margin (77.92%) than 88.73% of its industry peers.
In the last couple of years the Gross Margin of RBLX has remained more or less at the same level.
The Profit Margin and Operating Margin are not available for RBLX so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 77.92%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
RBLX Yearly Profit, Operating, Gross MarginsRBLX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40 -40 60

More info and screens

5

2. Health

2.1 Basic Checks

RBLX does not have a ROIC to compare to the WACC, probably because it is not profitable.
RBLX has more shares outstanding than it did 1 year ago.
The number of shares outstanding for RBLX has been increased compared to 5 years ago.
Compared to 1 year ago, RBLX has an improved debt to assets ratio.
RBLX Yearly Shares OutstandingRBLX Yearly Shares OutstandingYearly Shares Outstanding 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M
RBLX Yearly Total Debt VS Total AssetsRBLX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

An Altman-Z score of 4.12 indicates that RBLX is not in any danger for bankruptcy at the moment.
RBLX has a Altman-Z score of 4.12. This is amongst the best in the industry. RBLX outperforms 81.69% of its industry peers.
The Debt to FCF ratio of RBLX is 1.15, which is an excellent value as it means it would take RBLX, only 1.15 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 1.15, RBLX is doing good in the industry, outperforming 78.87% of the companies in the same industry.
A Debt/Equity ratio of 3.24 is on the high side and indicates that RBLX has dependencies on debt financing.
RBLX has a worse Debt to Equity ratio (3.24) than 76.06% of its industry peers.
Even though the debt/equity ratio score it not favorable for RBLX, it has very limited outstanding debt, so we won't put too much weight on the DE evaluation.
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF 1.15
Altman-Z 4.12
ROIC/WACCN/A
WACC9.25%
RBLX Yearly LT Debt VS Equity VS FCFRBLX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2018 2019 2020 2021 2022 2023 2024 0 200M 400M 600M 800M 1B

2.3 Liquidity

A Current Ratio of 1.02 indicates that RBLX should not have too much problems paying its short term obligations.
RBLX's Current ratio of 1.02 is in line compared to the rest of the industry. RBLX outperforms 54.93% of its industry peers.
A Quick Ratio of 1.02 indicates that RBLX should not have too much problems paying its short term obligations.
Looking at the Quick ratio, with a value of 1.02, RBLX is in line with its industry, outperforming 56.34% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.02
Quick Ratio 1.02
RBLX Yearly Current Assets VS Current LiabilitesRBLX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

More info and screens

6

3. Growth

3.1 Past

The Earnings Per Share has grown by an impressive 29.57% over the past year.
Looking at the last year, RBLX shows a very strong growth in Revenue. The Revenue has grown by 30.24%.
The Revenue has been growing by 47.93% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.58%
Revenue 1Y (TTM)30.24%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%30.63%

3.2 Future

Based on estimates for the next years, RBLX will show a quite strong growth in Earnings Per Share. The EPS will grow by 12.03% on average per year.
Based on estimates for the next years, RBLX will show a quite strong growth in Revenue. The Revenue will grow by 16.51% on average per year.
EPS Next Y-2.09%
EPS Next 2Y7.56%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue Next Year23.36%
Revenue Next 2Y21.68%
Revenue Next 3Y20.14%
Revenue Next 5Y16.51%

3.3 Evolution

The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
RBLX Yearly Revenue VS EstimatesRBLX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 2032 2B 4B 6B 8B 10B
RBLX Yearly EPS VS EstimatesRBLX Yearly EPS VS EstimatesYearly EPS VS Estimates 2020 2021 2022 2023 2024 2025 2026 2027 0 0.5 -0.5 -1 -1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

RBLX reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for RBLX. No positive earnings are expected for the next year.
Industry RankSector Rank
PE N/A
Fwd PE N/A
RBLX Price Earnings VS Forward Price EarningsRBLX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 40 -40 60 -60

4.2 Price Multiples

RBLX's Price/Free Cash Flow is on the same level as the industry average.
Industry RankSector Rank
P/FCF 67.29
EV/EBITDA N/A
RBLX Per share dataRBLX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4

4.3 Compensation for Growth

RBLX's earnings are expected to grow with 12.03% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y7.56%
EPS Next 3Y12.03%

More info and screens

0

5. Dividend

5.1 Amount

RBLX does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

ROBLOX CORP -CLASS A

NYSE:RBLX (5/30/2025, 8:04:01 PM)

After market: 86.95 -0.03 (-0.03%)

86.98

+2.19 (+2.58%)

Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryEntertainment
Earnings (Last)05-01 2025-05-01/bmo
Earnings (Next)07-30 2025-07-30/bmo
Inst Owners77.02%
Inst Owner Change-0.51%
Ins Owners5.75%
Ins Owner Change0.41%
Market Cap59.00B
Analysts75.38
Price Target72.32 (-16.85%)
Short Float %2.44%
Short Ratio1.72
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)24.92%
Min EPS beat(2)21.55%
Max EPS beat(2)28.29%
EPS beat(4)4
Avg EPS beat(4)20.7%
Min EPS beat(4)13.59%
Max EPS beat(4)28.29%
EPS beat(8)7
Avg EPS beat(8)15.39%
EPS beat(12)8
Avg EPS beat(12)3.94%
EPS beat(16)9
Avg EPS beat(16)-16.1%
Revenue beat(2)1
Avg Revenue beat(2)0.4%
Min Revenue beat(2)-2.6%
Max Revenue beat(2)3.4%
Revenue beat(4)3
Avg Revenue beat(4)3.31%
Min Revenue beat(4)-2.6%
Max Revenue beat(4)8.2%
Revenue beat(8)4
Avg Revenue beat(8)1.35%
Revenue beat(12)4
Avg Revenue beat(12)-5.15%
Revenue beat(16)4
Avg Revenue beat(16)-10.27%
PT rev (1m)6.04%
PT rev (3m)6.05%
EPS NQ rev (1m)-12.75%
EPS NQ rev (3m)-18.36%
EPS NY rev (1m)3.51%
EPS NY rev (3m)3.39%
Revenue NQ rev (1m)1.34%
Revenue NQ rev (3m)1.6%
Revenue NY rev (1m)1.96%
Revenue NY rev (3m)1.79%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 15.38
P/FCF 67.29
P/OCF 57.43
P/B 189.89
P/tB 425.26
EV/EBITDA N/A
EPS(TTM)-1.31
EYN/A
EPS(NY)-1.2
Fwd EYN/A
FCF(TTM)1.29
FCFY1.49%
OCF(TTM)1.51
OCFY1.74%
SpS5.66
BVpS0.46
TBVpS0.2
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -11.81%
ROE -283.19%
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 77.92%
FCFM 22.86%
ROA(3y)-16.3%
ROA(5y)-14.68%
ROE(3y)-744.81%
ROE(5y)-518.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.61%
GM growth 5Y0.48%
F-Score6
Asset Turnover0.51
Health
Industry RankSector Rank
Debt/Equity 3.24
Debt/FCF 1.15
Debt/EBITDA N/A
Cap/Depr 66.47%
Cap/Sales 3.92%
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.02
Quick Ratio 1.02
Altman-Z 4.12
F-Score6
WACC9.25%
ROIC/WACCN/A
Cap/Depr(3y)189.75%
Cap/Depr(5y)192.24%
Cap/Sales(3y)12.06%
Cap/Sales(5y)10.74%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.57%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%25.58%
EPS Next Y-2.09%
EPS Next 2Y7.56%
EPS Next 3Y12.03%
EPS Next 5YN/A
Revenue 1Y (TTM)30.24%
Revenue growth 3Y23.35%
Revenue growth 5Y47.93%
Sales Q2Q%30.63%
Revenue Next Year23.36%
Revenue Next 2Y21.68%
Revenue Next 3Y20.14%
Revenue Next 5Y16.51%
EBIT growth 1Y20.12%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year195.48%
EBIT Next 3Y54.41%
EBIT Next 5Y35.29%
FCF growth 1Y1181.11%
FCF growth 3Y4.75%
FCF growth 5Y113.37%
OCF growth 1Y165.65%
OCF growth 3Y7.65%
OCF growth 5Y52.65%